0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Wound Hemostatic Powder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-2C14451
Home | Market Reports | Health| Medical Devices & Equipment
Global Wound Hemostatic Powder Market Research Report 2023
BUY CHAPTERS

Wound Hemostatic Powder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2C14451
Report
April 2024
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Wound Hemostatic Powder - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Wound Hemostatic Powder - Market

Wound Hemostatic Powder - Market

The global market for Wound Hemostatic Powder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wound Hemostatic Powder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Wound Hemostatic Powder by region & country, by Type, and by Application.
The Wound Hemostatic Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Hemostatic Powder.
Market Segmentation

Scope of Wound Hemostatic Powder - Market Report

Report Metric Details
Report Name Wound Hemostatic Powder - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
  • Plant Hemostatic Powder
  • Gelatin Hemostatic Powder
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Surgery Center
  • Household
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, BD, Johnson & Johnson, MedTrade Products, C. R. Bard, Equimedical, MBP, Celox, Ferrosan Medical Devices, Betatech Medical, BioCer Entwicklungs, Hemostasis, Aegis Lifesciences, CSL Behring, Gelita Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Wound Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Wound Hemostatic Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Wound Hemostatic Powder in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Wound Hemostatic Powder - Market report?

Ans: The main players in the Wound Hemostatic Powder - Market are Pfizer, BD, Johnson & Johnson, MedTrade Products, C. R. Bard, Equimedical, MBP, Celox, Ferrosan Medical Devices, Betatech Medical, BioCer Entwicklungs, Hemostasis, Aegis Lifesciences, CSL Behring, Gelita Medical

What are the Application segmentation covered in the Wound Hemostatic Powder - Market report?

Ans: The Applications covered in the Wound Hemostatic Powder - Market report are Hospital, Clinic, Surgery Center, Household, Others

What are the Type segmentation covered in the Wound Hemostatic Powder - Market report?

Ans: The Types covered in the Wound Hemostatic Powder - Market report are Plant Hemostatic Powder, Gelatin Hemostatic Powder, Others

1 Market Overview
1.1 Wound Hemostatic Powder Product Introduction
1.2 Global Wound Hemostatic Powder Market Size Forecast
1.2.1 Global Wound Hemostatic Powder Sales Value (2019-2030)
1.2.2 Global Wound Hemostatic Powder Sales Volume (2019-2030)
1.2.3 Global Wound Hemostatic Powder Sales Price (2019-2030)
1.3 Wound Hemostatic Powder Market Trends & Drivers
1.3.1 Wound Hemostatic Powder Industry Trends
1.3.2 Wound Hemostatic Powder Market Drivers & Opportunity
1.3.3 Wound Hemostatic Powder Market Challenges
1.3.4 Wound Hemostatic Powder Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Wound Hemostatic Powder Players Revenue Ranking (2023)
2.2 Global Wound Hemostatic Powder Revenue by Company (2019-2024)
2.3 Global Wound Hemostatic Powder Players Sales Volume Ranking (2023)
2.4 Global Wound Hemostatic Powder Sales Volume by Company Players (2019-2024)
2.5 Global Wound Hemostatic Powder Average Price by Company (2019-2024)
2.6 Key Manufacturers Wound Hemostatic Powder Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Wound Hemostatic Powder Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Wound Hemostatic Powder
2.9 Wound Hemostatic Powder Market Competitive Analysis
2.9.1 Wound Hemostatic Powder Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Wound Hemostatic Powder Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wound Hemostatic Powder as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Plant Hemostatic Powder
3.1.2 Gelatin Hemostatic Powder
3.1.3 Others
3.2 Global Wound Hemostatic Powder Sales Value by Type
3.2.1 Global Wound Hemostatic Powder Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Wound Hemostatic Powder Sales Value, by Type (2019-2030)
3.2.3 Global Wound Hemostatic Powder Sales Value, by Type (%) (2019-2030)
3.3 Global Wound Hemostatic Powder Sales Volume by Type
3.3.1 Global Wound Hemostatic Powder Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Wound Hemostatic Powder Sales Volume, by Type (2019-2030)
3.3.3 Global Wound Hemostatic Powder Sales Volume, by Type (%) (2019-2030)
3.4 Global Wound Hemostatic Powder Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Surgery Center
4.1.4 Household
4.1.5 Others
4.2 Global Wound Hemostatic Powder Sales Value by Application
4.2.1 Global Wound Hemostatic Powder Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Wound Hemostatic Powder Sales Value, by Application (2019-2030)
4.2.3 Global Wound Hemostatic Powder Sales Value, by Application (%) (2019-2030)
4.3 Global Wound Hemostatic Powder Sales Volume by Application
4.3.1 Global Wound Hemostatic Powder Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Wound Hemostatic Powder Sales Volume, by Application (2019-2030)
4.3.3 Global Wound Hemostatic Powder Sales Volume, by Application (%) (2019-2030)
4.4 Global Wound Hemostatic Powder Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Wound Hemostatic Powder Sales Value by Region
5.1.1 Global Wound Hemostatic Powder Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Wound Hemostatic Powder Sales Value by Region (2019-2024)
5.1.3 Global Wound Hemostatic Powder Sales Value by Region (2025-2030)
5.1.4 Global Wound Hemostatic Powder Sales Value by Region (%), (2019-2030)
5.2 Global Wound Hemostatic Powder Sales Volume by Region
5.2.1 Global Wound Hemostatic Powder Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Wound Hemostatic Powder Sales Volume by Region (2019-2024)
5.2.3 Global Wound Hemostatic Powder Sales Volume by Region (2025-2030)
5.2.4 Global Wound Hemostatic Powder Sales Volume by Region (%), (2019-2030)
5.3 Global Wound Hemostatic Powder Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Wound Hemostatic Powder Sales Value, 2019-2030
5.4.2 North America Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Wound Hemostatic Powder Sales Value, 2019-2030
5.5.2 Europe Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Wound Hemostatic Powder Sales Value, 2019-2030
5.6.2 Asia Pacific Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Wound Hemostatic Powder Sales Value, 2019-2030
5.7.2 South America Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Wound Hemostatic Powder Sales Value, 2019-2030
5.8.2 Middle East & Africa Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Wound Hemostatic Powder Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Wound Hemostatic Powder Sales Value
6.2.1 Key Countries/Regions Wound Hemostatic Powder Sales Value, 2019-2030
6.2.2 Key Countries/Regions Wound Hemostatic Powder Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Wound Hemostatic Powder Sales Value, 2019-2030
6.3.2 United States Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Wound Hemostatic Powder Sales Value, 2019-2030
6.4.2 Europe Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Wound Hemostatic Powder Sales Value, 2019-2030
6.5.2 China Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.5.3 China Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Wound Hemostatic Powder Sales Value, 2019-2030
6.6.2 Japan Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Wound Hemostatic Powder Sales Value, 2019-2030
6.7.2 South Korea Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Wound Hemostatic Powder Sales Value, 2019-2030
6.8.2 Southeast Asia Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Wound Hemostatic Powder Sales Value, 2019-2030
6.9.2 India Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
6.9.3 India Wound Hemostatic Powder Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Wound Hemostatic Powder Product Offerings
7.1.5 Pfizer Recent Development
7.2 BD
7.2.1 BD Company Information
7.2.2 BD Introduction and Business Overview
7.2.3 BD Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BD Wound Hemostatic Powder Product Offerings
7.2.5 BD Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Introduction and Business Overview
7.3.3 Johnson & Johnson Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Johnson & Johnson Wound Hemostatic Powder Product Offerings
7.3.5 Johnson & Johnson Recent Development
7.4 MedTrade Products
7.4.1 MedTrade Products Company Information
7.4.2 MedTrade Products Introduction and Business Overview
7.4.3 MedTrade Products Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MedTrade Products Wound Hemostatic Powder Product Offerings
7.4.5 MedTrade Products Recent Development
7.5 C. R. Bard
7.5.1 C. R. Bard Company Information
7.5.2 C. R. Bard Introduction and Business Overview
7.5.3 C. R. Bard Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.5.4 C. R. Bard Wound Hemostatic Powder Product Offerings
7.5.5 C. R. Bard Recent Development
7.6 Equimedical
7.6.1 Equimedical Company Information
7.6.2 Equimedical Introduction and Business Overview
7.6.3 Equimedical Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Equimedical Wound Hemostatic Powder Product Offerings
7.6.5 Equimedical Recent Development
7.7 MBP
7.7.1 MBP Company Information
7.7.2 MBP Introduction and Business Overview
7.7.3 MBP Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.7.4 MBP Wound Hemostatic Powder Product Offerings
7.7.5 MBP Recent Development
7.8 Celox
7.8.1 Celox Company Information
7.8.2 Celox Introduction and Business Overview
7.8.3 Celox Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Celox Wound Hemostatic Powder Product Offerings
7.8.5 Celox Recent Development
7.9 Ferrosan Medical Devices
7.9.1 Ferrosan Medical Devices Company Information
7.9.2 Ferrosan Medical Devices Introduction and Business Overview
7.9.3 Ferrosan Medical Devices Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Ferrosan Medical Devices Wound Hemostatic Powder Product Offerings
7.9.5 Ferrosan Medical Devices Recent Development
7.10 Betatech Medical
7.10.1 Betatech Medical Company Information
7.10.2 Betatech Medical Introduction and Business Overview
7.10.3 Betatech Medical Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Betatech Medical Wound Hemostatic Powder Product Offerings
7.10.5 Betatech Medical Recent Development
7.11 BioCer Entwicklungs
7.11.1 BioCer Entwicklungs Company Information
7.11.2 BioCer Entwicklungs Introduction and Business Overview
7.11.3 BioCer Entwicklungs Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.11.4 BioCer Entwicklungs Wound Hemostatic Powder Product Offerings
7.11.5 BioCer Entwicklungs Recent Development
7.12 Hemostasis
7.12.1 Hemostasis Company Information
7.12.2 Hemostasis Introduction and Business Overview
7.12.3 Hemostasis Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Hemostasis Wound Hemostatic Powder Product Offerings
7.12.5 Hemostasis Recent Development
7.13 Aegis Lifesciences
7.13.1 Aegis Lifesciences Company Information
7.13.2 Aegis Lifesciences Introduction and Business Overview
7.13.3 Aegis Lifesciences Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Aegis Lifesciences Wound Hemostatic Powder Product Offerings
7.13.5 Aegis Lifesciences Recent Development
7.14 CSL Behring
7.14.1 CSL Behring Company Information
7.14.2 CSL Behring Introduction and Business Overview
7.14.3 CSL Behring Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.14.4 CSL Behring Wound Hemostatic Powder Product Offerings
7.14.5 CSL Behring Recent Development
7.15 Gelita Medical
7.15.1 Gelita Medical Company Information
7.15.2 Gelita Medical Introduction and Business Overview
7.15.3 Gelita Medical Wound Hemostatic Powder Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Gelita Medical Wound Hemostatic Powder Product Offerings
7.15.5 Gelita Medical Recent Development
8 Industry Chain Analysis
8.1 Wound Hemostatic Powder Industrial Chain
8.2 Wound Hemostatic Powder Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Wound Hemostatic Powder Sales Model
8.5.2 Sales Channel
8.5.3 Wound Hemostatic Powder Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Wound Hemostatic Powder Market Trends
    Table 2. Wound Hemostatic Powder Market Drivers & Opportunity
    Table 3. Wound Hemostatic Powder Market Challenges
    Table 4. Wound Hemostatic Powder Market Restraints
    Table 5. Global Wound Hemostatic Powder Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Wound Hemostatic Powder Revenue Market Share by Company (2019-2024)
    Table 7. Global Wound Hemostatic Powder Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Wound Hemostatic Powder Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Wound Hemostatic Powder Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Wound Hemostatic Powder Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Wound Hemostatic Powder Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Wound Hemostatic Powder
    Table 13. Global Wound Hemostatic Powder Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wound Hemostatic Powder as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Wound Hemostatic Powder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Wound Hemostatic Powder Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Wound Hemostatic Powder Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Wound Hemostatic Powder Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Wound Hemostatic Powder Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Wound Hemostatic Powder Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Wound Hemostatic Powder Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Wound Hemostatic Powder Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Wound Hemostatic Powder Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Wound Hemostatic Powder Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Wound Hemostatic Powder Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Wound Hemostatic Powder Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Wound Hemostatic Powder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Wound Hemostatic Powder Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Wound Hemostatic Powder Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Wound Hemostatic Powder Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Wound Hemostatic Powder Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Wound Hemostatic Powder Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Wound Hemostatic Powder Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Wound Hemostatic Powder Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Wound Hemostatic Powder Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Wound Hemostatic Powder Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Wound Hemostatic Powder Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Wound Hemostatic Powder Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Wound Hemostatic Powder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Wound Hemostatic Powder Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Wound Hemostatic Powder Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Wound Hemostatic Powder Sales Value by Region (2019-2024) & (%)
    Table 44. Global Wound Hemostatic Powder Sales Value by Region (2025-2030) & (%)
    Table 45. Global Wound Hemostatic Powder Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Wound Hemostatic Powder Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Wound Hemostatic Powder Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Wound Hemostatic Powder Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Wound Hemostatic Powder Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Wound Hemostatic Powder Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Wound Hemostatic Powder Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Wound Hemostatic Powder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Wound Hemostatic Powder Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Wound Hemostatic Powder Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Wound Hemostatic Powder Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Wound Hemostatic Powder Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer Wound Hemostatic Powder Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. BD Company Information
    Table 63. BD Introduction and Business Overview
    Table 64. BD Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. BD Wound Hemostatic Powder Product Offerings
    Table 66. BD Recent Development
    Table 67. Johnson & Johnson Company Information
    Table 68. Johnson & Johnson Introduction and Business Overview
    Table 69. Johnson & Johnson Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Johnson & Johnson Wound Hemostatic Powder Product Offerings
    Table 71. Johnson & Johnson Recent Development
    Table 72. MedTrade Products Company Information
    Table 73. MedTrade Products Introduction and Business Overview
    Table 74. MedTrade Products Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. MedTrade Products Wound Hemostatic Powder Product Offerings
    Table 76. MedTrade Products Recent Development
    Table 77. C. R. Bard Company Information
    Table 78. C. R. Bard Introduction and Business Overview
    Table 79. C. R. Bard Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. C. R. Bard Wound Hemostatic Powder Product Offerings
    Table 81. C. R. Bard Recent Development
    Table 82. Equimedical Company Information
    Table 83. Equimedical Introduction and Business Overview
    Table 84. Equimedical Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Equimedical Wound Hemostatic Powder Product Offerings
    Table 86. Equimedical Recent Development
    Table 87. MBP Company Information
    Table 88. MBP Introduction and Business Overview
    Table 89. MBP Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. MBP Wound Hemostatic Powder Product Offerings
    Table 91. MBP Recent Development
    Table 92. Celox Company Information
    Table 93. Celox Introduction and Business Overview
    Table 94. Celox Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Celox Wound Hemostatic Powder Product Offerings
    Table 96. Celox Recent Development
    Table 97. Ferrosan Medical Devices Company Information
    Table 98. Ferrosan Medical Devices Introduction and Business Overview
    Table 99. Ferrosan Medical Devices Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Ferrosan Medical Devices Wound Hemostatic Powder Product Offerings
    Table 101. Ferrosan Medical Devices Recent Development
    Table 102. Betatech Medical Company Information
    Table 103. Betatech Medical Introduction and Business Overview
    Table 104. Betatech Medical Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Betatech Medical Wound Hemostatic Powder Product Offerings
    Table 106. Betatech Medical Recent Development
    Table 107. BioCer Entwicklungs Company Information
    Table 108. BioCer Entwicklungs Introduction and Business Overview
    Table 109. BioCer Entwicklungs Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. BioCer Entwicklungs Wound Hemostatic Powder Product Offerings
    Table 111. BioCer Entwicklungs Recent Development
    Table 112. Hemostasis Company Information
    Table 113. Hemostasis Introduction and Business Overview
    Table 114. Hemostasis Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Hemostasis Wound Hemostatic Powder Product Offerings
    Table 116. Hemostasis Recent Development
    Table 117. Aegis Lifesciences Company Information
    Table 118. Aegis Lifesciences Introduction and Business Overview
    Table 119. Aegis Lifesciences Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Aegis Lifesciences Wound Hemostatic Powder Product Offerings
    Table 121. Aegis Lifesciences Recent Development
    Table 122. CSL Behring Company Information
    Table 123. CSL Behring Introduction and Business Overview
    Table 124. CSL Behring Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. CSL Behring Wound Hemostatic Powder Product Offerings
    Table 126. CSL Behring Recent Development
    Table 127. Gelita Medical Company Information
    Table 128. Gelita Medical Introduction and Business Overview
    Table 129. Gelita Medical Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Gelita Medical Wound Hemostatic Powder Product Offerings
    Table 131. Gelita Medical Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Wound Hemostatic Powder Downstream Customers
    Table 135. Wound Hemostatic Powder Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Wound Hemostatic Powder Product Picture
    Figure 2. Global Wound Hemostatic Powder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Wound Hemostatic Powder Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Wound Hemostatic Powder Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Wound Hemostatic Powder Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Wound Hemostatic Powder Report Years Considered
    Figure 7. Global Wound Hemostatic Powder Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Wound Hemostatic Powder Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Wound Hemostatic Powder Revenue in 2023
    Figure 10. Wound Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Plant Hemostatic Powder Picture
    Figure 12. Gelatin Hemostatic Powder Picture
    Figure 13. Others Picture
    Figure 14. Global Wound Hemostatic Powder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Wound Hemostatic Powder Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Wound Hemostatic Powder Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Wound Hemostatic Powder Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Wound Hemostatic Powder Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Hospital
    Figure 20. Product Picture of Clinic
    Figure 21. Product Picture of Surgery Center
    Figure 22. Product Picture of Household
    Figure 23. Product Picture of Others
    Figure 24. Global Wound Hemostatic Powder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Wound Hemostatic Powder Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Wound Hemostatic Powder Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Wound Hemostatic Powder Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Wound Hemostatic Powder Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Wound Hemostatic Powder Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Wound Hemostatic Powder Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Wound Hemostatic Powder Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Wound Hemostatic Powder Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Wound Hemostatic Powder Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Wound Hemostatic Powder Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Wound Hemostatic Powder Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Wound Hemostatic Powder Sales Volume (%), (2019-2030)
    Figure 41. United States Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Wound Hemostatic Powder Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Wound Hemostatic Powder Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Wound Hemostatic Powder Sales Value by Application (%), 2023 VS 2030
    Figure 62. Wound Hemostatic Powder Industrial Chain
    Figure 63. Wound Hemostatic Powder Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Healthcare Wipes Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17F7100
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Casting and Splinting Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-0Q12904
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Wearable Insulin Patch Pump Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33G12684
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Gastroesophageal pH Meter Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-26G6844
Fri May 17 00:00:00 UTC 2024

Add to Cart